Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

INTRODUCTION: Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open
Päätekijät: Mitra, Souvik, Jain, Amish, Ting, Joseph Y., Ben Fadel, Nadya, Drolet, Christine, Abou Mehrem, Ayman, Soraisham, Amuchou, Jasani, Bonny, Louis, Deepak, Lapointe, Anie, Dorling, Jon, Khurshid, Faiza, Hyderi, Abbas, Kumaran, Kumar, Bodani, Jaya, Weisz, Dany, Alvaro, Ruben, Adie, Mohammed, Stavel, Miroslav, Morin, Alyssa, Bhattacharya, Soume, Kanungo, Jaideep, Canning, Rody, Ye, Xiang Y, Hatfield, Tara, Gardner, Courtney E, Shah, Prakesh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Paediatrics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103361/
https://ncbi.nlm.nih.gov/pubmed/33952559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2021-050682
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia